Treatment outcome of bacteremia due to KPC-producing Klebsiella pneumoniae: superiority of combination antimicrobial regimens - Wikidata - wikimedia - TriplyDB

Treatment outcome of bacteremia due to KPC-producing Klebsiella pneumoniae: superiority of combination antimicrobial regimens

Treatment outcome of bacteremia due to KPC-producing Klebsiella pneumoniae: superiority of combination antimicrobial regimens

http://www.wikidata.org/entity/Q35867414

about

"Stormy waters ahead": global emergence of carbapenemases Klebsiella pneumoniae: Going on the Offense with a Strong Defense Beyond Susceptible and Resistant, Part III: Treatment of Infections due to Gram-Negative Organisms Producing Carbapenemases Tigecycline Treatment for Carbapenem-Resistant Enterobacteriaceae Infections: A Systematic Review and Meta-Analysis Bloodstream infections in intensive care unit patients: distribution and antibiotic resistance of bacteria New Insight on Epidemiology and Management of Bacterial Bloodstream Infection in Patients with Hematological Malignancies Tigecycline in treatment of multidrug-resistant Gram-negative bacillus urinary tract infections: a systematic review Vaccine approaches for multidrug resistant Gram negative infections What's new in multidrug-resistant pathogens in the ICU?Treatment Options for Carbapenem-Resistant Enterobacteriaceae Infections Clinical management of infections caused by multidrug-resistant Enterobacteriaceae Identification of Outer Membrane and Exoproteins of Carbapenem-Resistant Multilocus Sequence Type 258 Klebsiella pneumoniae Antibacterial Resistance in Patients with Hematopoietic Stem Cell Transplantation.Rapid susceptibility profiling of carbapenem-resistant Klebsiella pneumoniae.EUropean prospective cohort study on Enterobacteriaceae showing REsistance to CArbapenems (EURECA): a protocol of a European multicentre observational study.Retrospective analysis of fosfomycin combinational therapy for sepsis caused by carbapenem-resistant Klebsiella pneumoniae.Oral gentamicin gut decontamination for prevention of KPC-producing Klebsiella pneumoniae infections: relevance of concomitant systemic antibiotic therapy.Carbapenemase-producing Klebsiella pneumoniae bloodstream infections: lowering mortality by antibiotic combination schemes and the role of carbapenems.The global challenge of carbapenem-resistant Enterobacteriaceae in transplant recipients and patients with hematologic malignancies High dose tigecycline in critically ill patients with severe infections due to multidrug-resistant bacteria.Doripenem, gentamicin, and colistin, alone and in combinations, against gentamicin-susceptible, KPC-producing Klebsiella pneumoniae strains with various ompK36 genotypes.Epidemiology and clinical outcomes of patients with carbapenem-resistant Klebsiella pneumoniae bacteriuria.Surveillance of carbapenem-resistant Klebsiella pneumoniae: tracking molecular epidemiology and outcomes through a regional network.Clinical and laboratory considerations for the rapid detection of carbapenem-resistant Enterobacteriaceae.Role of newer and re-emerging older agents in the treatment of infections caused by carbapenem-resistant Enterobacteriaceae.IS5 element integration, a novel mechanism for rapid in vivo emergence of tigecycline nonsusceptibility in Klebsiella pneumoniae.Therapy of Infections due to Carbapenem-Resistant Gram-Negative Pathogens Carbapenem-resistant Enterobacteriaceae: a review of treatment and outcomes Treatment of carbapenem-resistant Klebsiella pneumoniae: the state of the art.Carbapenem-resistant Enterobacteriaceae: a menace to our most vulnerable patients Antibiotic-resistant gram-negative bacterial infections in patients with cancer.Doripenem MICs and ompK36 porin genotypes of sequence type 258, KPC-producing Klebsiella pneumoniae may predict responses to carbapenem-colistin combination therapy among patients with bacteremia.Clinical and microbiological characteristics of tigecycline non-susceptible Klebsiella pneumoniae bacteremia in Taiwan.Complex prosthetic joint infections due to carbapenemase-producing Klebsiella pneumoniae: a unique challenge in the era of untreatable infections.Impact of therapy and strain type on outcomes in urinary tract infections caused by carbapenem-resistant Klebsiella pneumoniae First report of chronic pulmonary infection by KPC-3-producing and colistin-resistant Klebsiella pneumoniae sequence type 258 (ST258) in an adult patient with cystic fibrosis Molecular epidemiological characteristics of Klebsiella pneumoniae associated with bacteremia among patients with pneumonia.Multi-drug-resistant Klebsiella pneumoniae pancreatitis: a new challenge in a serious surgical infection.In vitro pharmacodynamics of various antibiotics in combination against extensively drug-resistant Klebsiella pneumoniae.The association between colonization with carbapenemase-producing enterobacteriaceae and overall ICU mortality: an observational cohort study

P2860

Q21131125-A11E340C-5417-4876-9900-165EE4AFDD2A Q26745802-0B7CBA3C-AFE0-4838-ABCF-F44C6D4028BB Q26747580-6C73D7ED-F6DF-4EB9-AEF4-46A1F62F3E1F Q26764796-912A5928-3204-45E8-997F-87289BA63744 Q26795565-598758DA-89AC-4605-BC82-131E3DF0F418 Q26799580-06821411-7F65-4A58-9FD1-BB60119344C5 Q26823357-07993124-3129-4C50-B6B3-08284993007D Q27007042-184714E8-91E2-44EB-9370-9CE50E060F8B Q28071346-DA22C409-2E60-4863-BBA5-A0525688674A Q28082546-3166216F-DA64-4088-8385-C92064F2F070 Q28246841-0D66F3EF-DF7A-430D-BF20-94BBC3A40E72 Q28546573-D2164EC2-9F81-4825-BB24-5ACB2C11A94A Q30238945-198F5E30-DE3B-4624-992C-9517139FE3E0 Q30356154-CB973010-5ACE-4D0C-9527-75C425C26011 Q33552772-512FC885-284C-40AA-9FD2-DF6B739D098C Q33597689-E49999BA-A767-478B-81A7-ADD7981A7BF8 Q33622988-9313DE19-E9AD-4F16-ACE9-D02EC2EABBD9 Q33623060-26E6535D-2B88-4431-AC3A-E76D441EB77E Q33686940-FC244AB1-A635-44F2-BA65-00B4EFFB8CB2 Q33754471-8D119D09-9A9F-48AB-A718-7F5AD92B2164 Q33797981-E37259A5-CFCC-46B1-8B1C-3D1DB3BE4C4F Q33798101-F44C9569-D90F-4AFA-B2FD-89D406FABD94 Q33798238-1427EBFC-8155-4593-B671-E63B633645E6 Q33816207-CDAFD314-1DA1-47F8-A2BC-CFC79705309A Q33816251-6B22FEB1-BDED-4720-A99A-EA8F2620F210 Q34299132-D56FB716-58B4-4BA8-9293-8B0257D50F6B Q34303970-0C3D2FB0-E527-4C70-ADDF-92785F69F434 Q34320945-0EB2EC71-693A-4B8E-A5E2-446DC1F23B0D Q34327857-F6F66AF2-591F-42D9-BD43-5A76D5BE9346 Q34336456-A40CD392-523E-4465-A56E-F9BF7CD70FA2 Q34999880-481E436A-40E3-4656-BF68-30A4FFAFB685 Q35076943-DBC83398-063D-47D8-B486-9307DAB78272 Q35079204-566C3DED-C013-4B24-AA6C-02E2A673ED0D Q35106776-0586B7F4-BADE-431B-85B0-DDF2069C86B1 Q35167183-3609105A-D5C1-4A53-B9FF-E00294C5AA53 Q35193295-0CAA3D16-753F-4C4F-9F94-E49F406892DA Q35331017-54B65DBA-8CD5-4D11-9159-9FBD66037870 Q35376617-F6E47FCC-F959-4F62-A505-94D0B8EF1963 Q35385713-6F064212-F467-4A59-9C49-47B155D8186E Q35606408-67342DCB-AB70-42CA-8901-CB589D7BBAAC

P2860

Treatment outcome of bacteremia due to KPC-producing Klebsiella pneumoniae: superiority of combination antimicrobial regimens

http://www.wikidata.org/entity/Q35867414

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Treatment outcome of bacteremi ...... ination antimicrobial regimens

@ast

Treatment outcome of bacteremi ...... ination antimicrobial regimens

@en

type

label

Treatment outcome of bacteremi ...... ination antimicrobial regimens

@ast

Treatment outcome of bacteremi ...... ination antimicrobial regimens

@en

prefLabel

Treatment outcome of bacteremi ...... ination antimicrobial regimens

@ast

Treatment outcome of bacteremi ...... ination antimicrobial regimens

@en

P1433

Q35867414-5A3CC539-EC21-4621-9699-A05161964545

P1476

Q35867414-30656E0D-A1CB-4056-82E4-E178AD518F6A

P2093

Q35867414-63EAB432-DF54-4A30-99FA-2733F6068BAD

Q35867414-790D9C0D-CB6F-4838-89B9-1CAE58DFE622

Q35867414-9D91EED4-C85F-405F-AF99-8265563B28E6

Q35867414-CB3251D2-34A6-4C9C-80EA-832821A3025C

Q35867414-E9078F6D-7DF0-44AC-87D8-0F9B238B113E

Q35867414-F6D6C16D-4066-474F-89F7-B6B21FFA62E3

Q35867414-FB4D5486-7863-4E35-857E-B240E8137797

P2860

Q35867414-10BA5B59-6C04-4391-8CD8-FA78F68E0FB3

Q35867414-18F0FFF4-CE98-4DA1-B5C4-1C0A2CD92A29

Q35867414-20CF4E84-B066-4984-BE7F-38B6F5CE4398

Q35867414-311F1F7B-790E-415C-8649-69E794B020ED

Q35867414-329C6245-D8A9-41A7-8F68-B9E5FA5DA6FF

Q35867414-56DB3108-AD88-4F73-A652-A4A1650E1123

Q35867414-62921217-345A-4EDC-B84D-EA9C2E88E738

Q35867414-7DB01AA2-B1B1-43B9-B5A0-825ABDD1C444

Q35867414-855B9EAE-29BC-4F75-AFDA-5787C5343871

Q35867414-96DABFE2-A0A7-4496-B8F9-DA1D879EC14A

P304

Q35867414-E7703F64-6044-4940-9CFA-E37AB6327CAA

P31

Q35867414-59FFF4DA-1051-421D-B5F3-38D4F7DD949F

P356

Q35867414-C305B0CA-D771-4768-8F50-B503DB8A9661

P407

Q35867414-0C95EF8A-43E2-4EF7-994A-081ADDE2AD8E

P433

Q35867414-ABF9481F-C39C-4532-9814-89E81C4A6BA4

P478

Q35867414-DECD393B-7760-43F1-8D7D-EE348C246586

P50

Q35867414-331EFB96-C0F9-4636-B994-60146EE56659

Q35867414-C67FB911-DDFA-4FD7-B7E6-5E665CF3C544

P577

Q35867414-706173F6-930A-4DD4-89DE-BC1084519F36

P698

Q35867414-0C49ACD2-8D43-46C7-8768-08C05E2CEFA6

P921

Q35867414-22CF9538-F098-481D-9ED3-BD47728EC81B

P932

Q35867414-A7D51086-B672-4C69-AF5A-E083A086274D

P356

P1433

Antimicrobial Agents and Chemotherapy

P1476

Treatment outcome of bacteremi ...... ination antimicrobial regimens

@en

P2093

Brian A Potoski

http://www.w3.org/2001/XMLSchema#string

Bruce Polsky

http://www.w3.org/2001/XMLSchema#string

Emilia Sordillo

http://www.w3.org/2001/XMLSchema#string

Gabriel Sandovsky

http://www.w3.org/2001/XMLSchema#string

Jennifer M Adams-Haduch

http://www.w3.org/2001/XMLSchema#string

Mary C Kilayko

http://www.w3.org/2001/XMLSchema#string

Zubair A Qureshi

http://www.w3.org/2001/XMLSchema#string

P2860

APACHE II: a severity of disease classification system

Outcomes and genetic relatedness of carbapenem-resistant enterobacteriaceae at Detroit medical center.

Risk factors and outcomes associated with acquisition of colistin-resistant KPC-producing Klebsiella pneumoniae: a matched case-control study.

Risk factors and clinical impact of Klebsiella pneumoniae carbapenemase-producing K. pneumoniae.

Detection and treatment options for Klebsiella pneumoniae carbapenemases (KPCs): an emerging cause of multidrug-resistant infection.

Carbapenem-resistant Enterobacteriaceae: epidemiology and prevention.

Rapid spread of carbapenem-resistant Klebsiella pneumoniae in New York City: a new threat to our antibiotic armamentarium.

Population pharmacokinetics of colistin methanesulfonate and formed colistin in critically ill patients from a multicenter study provide dosing suggestions for various categories of patients

Colistin-resistant, Klebsiella pneumoniae carbapenemase (KPC)-producing Klebsiella pneumoniae belonging to the international epidemic clone ST258.

Clinical characteristics of bacteraemia caused by extended-spectrum β-lactamase-producing Enterobacteriaceae in the era of CTX-M-type and KPC-type β-lactamases.

P304

2108-2113

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.06268-11

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

56

http://www.w3.org/2001/XMLSchema#string

P50

David L Paterson

P577

2012-01-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22252816

http://www.w3.org/2001/XMLSchema#string

P921

Klebsiella pneumoniae

P932

3318350

http://www.w3.org/2001/XMLSchema#string